Literature DB >> 12736717

Predictive factors for remission and death in 73 patients with autoimmune hepatitis in Japan.

Teruko Hino1, Ryukichi Kumashiro, Tatsuya Ide, Yuriko Koga, Kunihide Ishii, Eisuke Tanaka, Yasuyo Morita, Akiko Hisamochi, Shiro Murashima, Kazuo Tanaka, Kei Ogata, Reiichiro Kuwahara, Michio Sata.   

Abstract

The prognosis of patients with autoimmune hepatitis (AIH) has not been clearly defined. The aim of this study was to define the prognostic factors of AIH in a population with long-term follow-up in Japan. Seventy-three patients who were diagnosed as having type 1 AIH between January, 1972 - August, 1999 were enrolled in this study. Initial treatment included prednisolone (PSL) (n=62), other drug regimens (n=7), and none (n=4). We examined the relation between several factors obtained at diagnosis in relation to disease activity found at the final observation point (January, 2000 - April, 2000). Multivariate logistic regression and Cox regression were used for statistical analysis. During the observation period, 8 patients died of the following: hepatic failure (n=4), hepatocellular carcinoma (n=1), severe infection (n=1), and unknown causes (n=2). At the end point, the number of patients in complete remission was 13, those with a normal alanine aminotransferase (ALT) level requiring some treatment was 35, and those with an abnormal ALT level despite medication was 17. Factors related to remission were total bilirubin (TB) (Odds ratio, 0.87), and immunoglobulin G (IgG) (Odds ratio, 1.00). Factors related to death were the aspartate aminotransaminase (AST)/ALT ratio (Odds ratio, 11.67) and response to initial PSL regimen (Odds ratio, 0.03). The results of this study show an importance of achieving a good PSL response at onset, and that initial TB, the AST/ALT ratio, and IgG levels are useful for therapeutic strategy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12736717

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  6 in total

Review 1.  Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysis.

Authors:  Aylin Tansel; Lior H Katz; Hashem B El-Serag; Aaron P Thrift; Mayur Parepally; Mohammad H Shakhatreh; Fasiha Kanwal
Journal:  Clin Gastroenterol Hepatol       Date:  2017-02-12       Impact factor: 11.382

2.  Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1.

Authors:  Teruko Hino-Arinaga; Tatsuya Ide; Ryoko Kuromatsu; Ichiro Miyajima; Kei Ogata; Reiichiro Kuwahara; Akiko Hisamochi; Takuji Torimura; Michio Sata
Journal:  J Gastroenterol       Date:  2011-12-21       Impact factor: 7.527

3.  The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all-cause and cardiovascular mortality in patients with type 2 diabetes.

Authors:  Giacomo Zoppini; Vittorio Cacciatori; Carlo Negri; Vincenzo Stoico; Giuseppe Lippi; Giovanni Targher; Enzo Bonora
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

4.  Prognostic factors for remission, relapse, and treatment complications in type 1 autoimmune hepatitis.

Authors:  Nitipat Sandusadee; Wattana Sukeepaisarnjaroen; Tanita Suttichaimongkol
Journal:  Heliyon       Date:  2020-04-10

5.  microRNA-143-3p attenuated development of hepatic fibrosis in autoimmune hepatitis through regulation of TAK1 phosphorylation.

Authors:  Hanxiao Tu; Dazhi Chen; Chao Cai; Qianjing Du; Hongwei Lin; Tongtong Pan; Lina Sheng; Yuedong Xu; Teng Teng; Jingjing Tu; Zhuo Lin; Xiaodong Wang; Rui Wang; Lanman Xu; Yongping Chen
Journal:  J Cell Mol Med       Date:  2019-12-06       Impact factor: 5.310

6.  De-Ritis Ratio Is Associated with Mortality after Cardiac Arrest.

Authors:  Zhengri Lu; Genshan Ma; Lijuan Chen
Journal:  Dis Markers       Date:  2020-11-04       Impact factor: 3.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.